Because the world can’t afford another COVID-19, we are working with a coalition of partners to help the global community be ready next time. We build support for robust disease surveillance networks and rapid response systems that can protect against future outbreaks wherever they may arise.
Allan Golston, president of U.S. Programs at the Bill & Melinda Gates Foundation, delves into the foundation’s strategy for education during and after COVID-19 to ensure successful and equitable online…
Amy Carter, director of Community Engagement, discusses the two-pronged approach the foundation is taking to tackle COVID-19 in Seattle: deploying money and expertise.
Monalisa Chatterji, a senior program officer for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team, works on the discovery of novel candidate therapeutics.
Interview with Trevor Mundel on COVID-19. Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The…
Interview with Valerie Nkamgang Bemo on COVID-19. Bemo manages the Bill & Melinda Gates Foundation’s investments that support communities affected by natural disasters and complex emergencies.
Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation’s Discovery & Translational Sciences team.
In 2016, as Nigeria prepared to announce two years without a case of wild poliovirus, two children in northern Nigeria tested positive for polio. In an instant, the country’s track…
